B

bluebird bio

D
BLUE
USD
-0.0046
(-0.9287%)
Market Closed
68,304.00
Volume
-1.64
EPS
-
Div Yield
-0.198664
P/E
95,153,396.16
Market Cap
Today
-0.9287%
1 Week
-14.587%
1 Month
-29.079%
6 Months
-65.075%
12 Months
-84.737%
Year To Date
-64.442%
All Time
-98.545%

Title:
bluebird bio

Sector:
Healthcare
Industry:
Biotechnology
bluebird bio Inc is a biotechnology company engaged in researching, developing, and commercializing potentially curative gene therapies for severe genetic diseases based on its proprietary lentiviral vector (LVV) gene addition platform. The Company operates in a single segment, focusing on researching, developing and commercializing potentially transformative gene therapies for severe genetic diseases.
Do you need help or have a question?